Physician

Abdul T Razack, M.D.

According to 2025 Medicare claims, Abdul Razack, M.D. (NPI: 1144294406) practices gastroenterology in the Cleveland, OH market, with the plurality of this provider's patient population coming from Lorain, OH. This provider's primary affiliated billing organization is MERCY HEALTH PHYSICIANS LORAIN SPECIALTY CARE LLC (NPI: 1972126381; TIN: 851056783) and primary practice location at 44053-1654. Razack is affiliated with the Mercy Health Select, LLC (ACO ID: A1215) and Caravan Health ACO 50 LLC (ACO ID: A5160), participating under the MSSP model.

Razack's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 436 traditional Medicare patients, billed 894 HCPCS/CPT codes, and received $77,765 in Medicare payments. The top billing code was 45385 (Removal of polyps or growths of large bowel using an endoscope with mechanical snare). Part D data shows 1,549 prescription claims across 644 beneficiaries totaling $565,646 in drug costs, led by Creon (Lipase/Protease/Amylase). Open Payments data shows 6 records totaling $634. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $213,748 to $77,765. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $435,892 and ending at $565,646. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	922	2,436	$213,748
2016	980	2,500	$203,739
2017	894	2,177	$182,895
2018	793	1,837	$158,774
2019	684	1,444	$135,391
2020	497	1,098	$98,267
2021	561	1,266	$122,552
2022	500	1,120	$101,788
2023	461	1,036	$92,592
2024	436	894	$77,765

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	463	1,064	$435,892
2016	435	1,112	$618,865
2017	505	1,197	$368,325
2018	552	1,120	$316,436
2019	674	1,192	$418,566
2020	518	1,219	$343,742
2021	554	1,387	$377,098
2022	502	1,436	$548,064
2023	571	1,441	$582,770
2024	644	1,549	$565,646

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
45385	Removal of polyps or growths of large bowel using an endoscope with mechanical snare	91	91	$191
45380	Biopsy of large bowel using a flexible endoscope	111	111	$74
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	98	98	$69
43239	Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope	71	72	$66
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	124	166	$59

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Creon	Lipase/Protease/Amylase	24	826	$79,079
Zenpep	Lipase/Protease/Amylase	11	627	$50,363
Linzess	Linaclotide	54	2,220	$38,305
Mesalamine	Mesalamine	46	2,755	$31,698
Mesalamine Er	Mesalamine	58	3,250	$16,389

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	6	$634	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Abdul T. Razack, M.D.?

Tedicare shows public-source Medicare data for Abdul T. Razack, M.D. (NPI 1144294406), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abdul T. Razack, M.D. have ACO affiliation data?

Abdul T. Razack, M.D. is shown with ACO affiliation data for Mercy Health Select, LLC (MSSP, ACO ID A1215) and Caravan Health ACO 50 LLC (MSSP, ACO ID A5160).

What billing organization is linked to Abdul T. Razack, M.D.?

Abdul T. Razack, M.D. is linked to MERCY HEALTH PHYSICIANS LORAIN SPECIALTY CARE LLC (billing NPI 1972126381) in the available physician profile data.

Does Abdul T. Razack, M.D. have Open Payments data?

Abdul T. Razack, M.D. has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.